Latest News

The latest in our partnerships, collaborations, company updates, and milestones.

Inimmune to Present Key Updates at the 2025 World Vaccine Congress in Washington, DC April 21-24

Inimmune Welcomes Dr. Heather Madsen of Hatteras Venture Partners to Board of Directors

Inimmune to present successful Phase I allergy trial results at the American Academy of Allergy Asthma & Immunology meeting in San Diego, February 28-March 3, 2025

SPI Pharma, Inc. and Inimmune, Corp. Launch Partnership to Commercialize Advanced Adjuvant Systems

Insilico Medicine and Inimmune Achieved collaboration to Revolutionize Immunotherapy with AI-Driven Drug Discovery

Medinvest Oncology Investor Conference
Inimmune to Present at the Medinvest Oncology Conference on INI-4001
World Vaccine Congress
Inimmune to present an Update on Clinical Stage Vaccine Adjuvant and Immunotherapy Programs at the World Vaccine Congress in Washington DC on April 1st
Medinvest Oncology Investor Conference
Inimmune to Present on Our Novel Cancer Immunotherapy INI-4001
World Vaccine Congress (West Coast)
Inimmune to Provide an Update on Our Vaccine and Adjuvant Programs